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Background: Colposcopy, the key step in the management of women with abnormal Pap smear results, is a visual
technique prone to observer variation, which implies the need for prolonged apprenticeship, continuous training,
and quality assurance (QA) measures. Colposcopy QA programmes vary in level of responsibility of organizing
subjects, geographic coverage, scope, model, and type of actions. The programmes addressing the clinical
standards of colposcopy (quality of examination and appropriateness of clinical decisions) are more limited in space
and less sustainable over time than those focused on the provision of the service (resources, accessibility, etc.). This
article reports on the protocol of a QA programme targeting the clinical quality of colposcopy in a population-
based cervical screening service in an administrative region of northern Italy.
Methods/design: After a situation analysis of local colposcopy audit practices and previous QA initiatives, a
permanent web-based QA programme was developed. The design places more emphasis on providing education
and feedback to participants than on testing them. The technical core is a log-in web application accessible on the
website of the regional Administration. The primary objectives are to provide (1) a practical opportunity for
retraining of screening colposcopists, and (2) a platform for them to interact with colposcopists from other settings
and regions through exchange and discussion of digital colposcopic images. The retraining function is based on
repeated QA sessions in which the registered colposcopists log-in, classify a posted set of colpophotographs, and
receive on line a set of personal feedback data. Each session ends with a plenary seminar featuring the presentation
of overall results and an interactive review of the test set of colpophotographs. This is meant to be a forum for an
open exchange of views that may lead to more knowledge and more diagnostic homogeneity. The protocol
includes the criteria for selection of colpophotographs and the rationale for colposcopic gold standards.
Discussion: This programme is an ongoing initiative open to further developments, in particular in the area of
basic training. It uses the infrastructure of the internet to give a novel solution to technical problems affecting
colposcopy QA in population-based screening services.
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Colposcopy, a visual examination of the uterine cervix
and vagina using a lighted field microscope after the ap-
plication of a diluted solution of acetic acid and Lugol’s
iodine solution as staining agents, is the key step in the
management of women with abnormal Pap smear results.
Colposcopy aims at detecting macroscopic changes in tis-
sue features such as colour and morphology. Comparison
of these features with established patterns of disease en-
ables the clinician to classify the lesions and to identify
abnormal areas that may need to be biopsied in order to
detect precancerous or cancerous lesions [1].
However, the colposcopic impression of any abnormality
is prone to observer variation. This is potentially associ-
ated with low intra- and interobserver agreement in iden-
tifying cervical lesions, and high biopsy sampling error
rate. An important study has raised concern that errors in
the selection of biopsy site may lead to low sensitivity for
detection of high-grade cervical intraepithelial neoplasia
(CIN) [2]. The importance of these problems is heightened
by the increasing use of human papillomavirus virus
(HPV) testing for cervical cancer screening. Because HPV
test has high sensitivity but limited specificity, the role of
colposcopy in the identification of patients with clinically
significant lesions becomes even more crucial [3].
To cope with these problems, some novel approaches
have been suggested including the identification of a
limited set of well-defined and reproducible colposcopic
features of cervical abnormalities, the development of
computer-assisted diagnosis, the collection of additional
biopsy specimens from the worst-looking lesion and other
abnormal areas, and the collection of random biopsy spec-
imens from all cervical quadrants [3].
At present, however, the diagnostic performance of a
colposcopist depends solely on his visual skills and, thus,
on his experience and competence in comparing the
perceived pattern with established features of premalig-
nant and malignant lesions [1]. As a consequence, col-
poscopy requires a period of apprenticeship, continuous
formal training, sufficient workload and, more important,
auditing and quality assurance (QA) measures.
In this article, we report the protocol of a colposcopy
QA programme that is underway in a population-based
cervical screening setting in the Emilia-Romagna Region
of northern Italy.
(b) Study setting
The Emilia-Romagna Region, one of the largest adminis-
trative regions of Italy, is currently subdivided into 11
health care districts. General characteristics of cervical
screening service in the area are described elsewhere
[4-6]. In brief, every three years since 1997, residentwomen aged 25–64 years (n = 1,248,000 on 1 January
2012) are invited by a personal letter to attend for a free
Pap smear. Current response rate is 58% [7]. Pap smears
are taken by midwives at the district screening centres.
Abnormal Pap smear results are notified to women by
telephone. Colposcopy assessment is carried out free of
charge by gynaecologists and gynecologist-oncologists at
selected clinics. These follow guidelines from the regional
Department of Health [8].
Routine audit and QA initiatives are under the responsi-
bility of the regional Department of Health. Since 2006, an
annual statistical audit has been done according to guide-
lines from the National Centre for Screening Monitoring
(Italian: Osservatorio Nazionale Screening) [7]. QA initia-
tives are designed by specially appointed steering commit-
tees composed of specialists from the screening centres
and the public hospitals [5,6].
In 2009, the Steering Committee for Clinical QA in
Cervical Screening (hereby referred to as ‘the Committee’),
of which we are current members, received the mandate
to develop a QA programme for colposcopy clinics. The
programme protocol was written in a simplified manner
to help potential participants during the recruitment
process. The current paper presents an expanded and
partly updated version, which was written after full imple-
mentation of the programme in the form of a retrospect-
ive article.
Conceptualisation of colposcopy QA
The Committee performed a review of the literature in
order to establish a conceptual framework for the plan-
ning and design of the programme.
(a) Basic perspective
The numerous terms used to describe the quality in
health care as well as the tools used to improve it vary
between countries, between stakeholders, and over time
[9]. Since there is no international classification of these
concepts, the terms are often used interchangeably al-
though there can be differences in meaning. In Italy, this
is the case for ‘colposcopy audit’ and ‘colposcopy QA’.
These terms, in fact, indicate different perspectives.
Colposcopy audit The objectives of colposcopy audit ac-
tivities are to review and evaluate the adequacy and re-
sources of colposcopy clinics, the quality of colposcopic
examination, and the appropriateness of clinical decisions
[10]. They use several different techniques including,
for example: (1) assessment of the degree of adherence
of colposcopy clinics to standards of practice [11-13];
(2) evaluation of survey data from colposcopy clinics on
the management of defined categories of cervical lesions
[14]; (3) random or systematic retrospective review of
colposcopic impressions reported in case notes with
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histological diagnosis [15-18]; (4) review of colposcopy
records of patients diagnosed with cervical cancer [19];
(5) collection of information by focus groups of patients or
by questionnaire; and (6) analysis of complaints data [10].
Colposcopy QA Colposcopy audit can be designed to
stand alone or be a part of a QA scheme. In fact, the
definition of standards and the measurement of their
achievement are the basis for a QA scheme. However,
the challenge for a colposcopy QA team is not only to
identify the areas of colposcopy practice most susceptible
of improvement but to target them with appropriate
actions. The central component of a QA programme is
the development of techniques capable of improving
the performance of colposcopy [10].
Often, QA is also identified with the process of ac-
creditation. There is a growing realisation that these two
concepts should be kept separate. QA focuses on sup-
port for health services in the development of quality
improvement processes.
(b) Level of responsibility
Colposcopy QA can be carried out by health authorities,
public health agencies, scientific organisations, profes-
sional bodies, spontaneous groups, or individuals who
systematically or occasionally attempt to review and im-
prove their work or that of their teams in a rational
manner [10]. The institutional level of responsibility of
the individual organiser or organising centre has several
implications for the planning of the programme, in par-
ticular for the geographical coverage and the degree of
continuity in the long term [20].
(c) Scope
The scope of colposcopy QA activities may focus on
either or both of two main areas, namely:
 the provision of the service (for example: resources,
infrastructure, accessibility, and adequacy indicators
such as the proportion of patients with recording of
the reason for referral); and
 the clinical standards of the service and the
appropriateness of clinical decisions.
(d) Model
There are some paradigmatic models of colposcopy QA.
Agreement studies Obtaining data on the level of diag-
nostic agreement on the interpretation of colpophotographs
[21] as well as of their digital counterparts [22] is useful for
both audit and QA purposes. Agreement coefficients can
be computed for a group of observers as a whole, for each
observer, and for specific colposcopic patterns. Agreementstudies are often associated with intensive courses in the
form of interactive slide seminars of study cases [21].
Multidisciplinary colposcopy meetings While most
designs for colposcopy QA, including agreement studies,
involve the re-evaluation of selected archival material
and rely on education, multidisciplinary colposcopy
meetings are a real-time approach [23,24] that is directly
aimed at correcting certain diagnostic errors. According
to the guidelines of the National Health Service cervical
screening programme [25], multidisciplinary meetings
should focus on cases with significant mismatch between
colposcopy, cytopathology, and histopathology. The
identification of patients with false-positive and false-
negative diagnoses permits avoidance of over-treatment
and safe treatment of high-grade precancerous lesions.
To this end, multidisciplinary meetings should be held
often enough to allow for timely care of patients.
On-site colposcopy QA visits A remarkable example of
on-site colposcopy QA visits can be found in the Irish
cervical screening programme [26]. The process, which
is periodically repeated, begins with a questionnaire sur-
vey of colposcopy clinics. As a second phase, a specialist
team visits each clinic to perform an on-site audit of the
levels of provision of the service. The visit focuses on
staffing, infrastructure, communication, continuing med-
ical education, fail-safe procedures, written protocols,
waiting times, and diagnostic indicators. After the visit, a
written report is provided to the colposcopy staff and
the hospital management to identify priority needs.
In Italy, the National Centre for Disease Prevention and
Control (Italian: Centro Nazionale per la Prevenzione e il
Controllo delle Malattie) has launched a pilot project for
on-site visits designed for those screening centres in which
efficient monitoring systems have not been set up [27].
(e) Action
Potential colposcopy QA interventions vary in relation
to the objectives pursued. In particular:
 insufficient levels of resources may require
administrative decisions;
 adequacy indicators can be improved through
technical actions, although feedback of audit
information alone may be sufficient to bring about
the desired correction;
 failures to achieve clinical standards warrant more
structured and direct approaches, such as the
professional retraining of colposcopists.
(f) Interrelated characteristics of QA programmes
Most of the above aspects are interrelated. The largest
colposcopy QA programmes, such as those implemented
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provision of the service (that is, infrastructure, accessibil-
ity, etc.) rather than on its clinical standards. For example,
this is the case for on-site QA visit programmes. In gen-
eral, these approaches do not involve direct assessment of
the physician’s ability to perform a colposcopic examin-
ation. Indirect approaches, such as the comparison of the
reported colposcopic impression vs. final histological diag-
nosis [15-18], are more common.
Agreement studies are more colposcopist-oriented.
They are mainly devoted to improve the quality of
colposcopic examination and the appropriateness of
clinical decisions. On the other hand, they are seldom
conducted on a regional [28] or community [21] basis.
They generally target undefined samples [29,30] or se-
lected groups [31,32] of gynaecologists. Most of these
considerations also apply to multidisciplinary colposcopy
meetings.
Limitations in geographical coverage of agreement
studies and multidisciplinary colposcopy meetings are
coupled with problems of continuity in the long term.
These schemes are more often introduced on a voluntary
basis than through legislation, and are more susceptible to
closure or interruption [20].
In summary, QA programmes targeting the clinical
standards of colposcopy practice are more limited in
space and time than those focused on the provision of
the service. This is a serious problem, because the ultimate
rationale of an organised cervical screening service is to
offer standardised procedures of controlled and assured
technical quality to a vast population. Variations in the
clinical quality of colposcopy between centres may hamper
the effectiveness of screening and cause health inequal-
ities. As a consequence, colposcopy QA programmes
should aim at improving both the average clinical level
and the homogeneity of the diagnostic performance.




In order to have an overview of the situation in which
the QA programme was to take place, the Committee
gathered the available information relating to the pat-
terns of provision and the clinical quality of colposcopy
in the local screening service. Two main sources of
information were identified.
(a) Colposcopy audit data
Colposcopy audit data were obtained from the archives of
the regional Department of Health. Up to 2005, the main
performance indicators of the screening service, including
some indicators of colposcopy assessment for women with
abnormal Pap smear results, were monitored using astandard set of aggregate data annually collected by the
district screening units. In 2006, the electronic datasheet
developed by the National Centre for Screening Monitor-
ing for the annual national survey of local programmes
was adopted. In the most recent data (Additional file 1),
the regional average level of quality of colposcopy service
was acceptable, but with considerable variation between
health care districts. The proportion of patients with CIN3
and carcinoma classified into the two highest categories of
colposcopic impression was among the most fluctuating
indicators.
(b) Previous QA initiatives
Between 2000 and 2003, the previous Committee imple-
mented some on-site QA initiatives targeting the screen-
ing colposcopists [33]. In 2000, a two-day course was
held that covered the distinction of normal from abnor-
mal transformation zone, the grading of colposcopic
abnormalities (see below: Colposcopic variables), and
the identification of invasive cancer. A teaching set of
480 slides obtained with a standard cervicograph was
used. Before and after the course, 50 test slides were
projected onto a screen, and classified for colposcopic
impression, visibility of the squamocolumnar junction
(SCJ), and indication for biopsy. In a subsequent sem-
inar, the before-after variation in interobserver agree-
ment was presented and the most controversial images
were discussed in an interactive learning session. This
programme was repeated in 2001.
In 2002, copies of a newly selected set of 50 slides
were sent to all district screening units, and were classified
by local colposcopists according to the above variables. A
concluding plenary seminar was held.
In 2003, each colposcopist received a CD-Rom
containing a specifically designed software package and
a new set of 50 digital colposcopic images, which were
classified in a fixed time. Responses were returned via
e-mail. As in previous QA rounds, a plenary seminar was
held to review the results and the most problematic
images.
The Committee’s opinion on these initiatives was that
they were difficult to set up, expensive, time consuming,
and inaccessible to external review. Conversely, their
design was appropriate for assessing and improving the
colposcopists’ competence.
From the findings of this situation analysis, the
Committee concluded that:
 there were sufficient justifications for implementing
a QA programme in colposcopy;
 the programme had to use the communication
infrastructure of the internet, be implemented on a
permanent basis, and be more efficient than
previous residential QA initiatives;
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was sufficient to cover the essential aspects of
colposcopy assessment; and
 the variation of the indicators of the diagnostic
process across health care districts was large.
Reducing this variation was a priority objective.Current technical level of digital colposcopy imaging
Since colposcopy is an in vivo procedure, there are ob-
jective difficulties in comparing the results a posteriori
with other examiners as well as a QA team [21]. The
problems can be summarized into two broad categories:
(1) it is difficult to obtain highly representative still images
and videos that can allow the colposcopic examination
to be quality-assured by other observers; and (2) con-
ventional binocular colposcopes do not provide neither
guidance for biopsy nor documentation of the biopsy
procedure.
For years, studies of interobserver variation have used
colpophotographs (also referred to as cervigrams). The
colpophotograph is a 35-mm picture of the cervix taken
under magnification during colposcopy approximately
one minute after acetic acid application.
With the introduction of digital video colposcopes, the
need to project images has been eliminated, since an ob-
server can view them on the computer screen. Com-
pared with colpophotographs, digital colposcopic images
suffer from a lower level of standardization. In general,
however, the diagnostic reliability of digital colposcopy
compared with conventional colposcopy is considered
acceptable [1]. Particularly if images are free from arti-
facts and imperfections, digital colposcopy can be used
for the visual assessment of cervical abnormalities.
The introduction of the internet and e-mail commu-
nications has greatly facilitated the review of digital
colposcopic images outside the examination room.
There are two main types of on-line transmission of
digitalized images [1]. In the ‘computer-based’ transmis-
sion, images are first stored using a computer software
and then forwarded, whereas the ‘network-based’ trans-
mission uses an infrastructure composed of a technologic-
ally advanced hardware and rapid telecommunication
lines. The latter system has only a slightly greater sensitiv-
ity for the detection of high-grade cervical lesions [34,35].
Based on current knowledge [1], the Committee consid-
ered the technical level of digital colposcopy imaging to be
acceptable for the purposes of a web-based colposcopy
QA programme.Definition and objectives
The Committee developed the programme. The tech-
nical basis consists of an easy-to-handle software that ispermanently made available at a log-in web application.
The objectives of the programme are to provide:
 a practical opportunity for permanent retraining of
the colposcopists’ staff of the regional screening
service; and
 a platform for them to load and exchange their own
digital colposcopic images, to present and obtain
feedback on their colposcopic impressions, and to
interact with colposcopists from different settings
and geographical regions.
The programme has not administrative functions. It is
not designed to: set up a monitoring system for purposes
of central control; rank the colposcopists; certify their
competence; collect single screening centre’s data for
accreditation purposes; and provide data to national
screening authorities. The programme is colposcopist-
oriented, and places more emphasis on providing educa-
tion and feedback to colposcopists than on testing them.
The objectives and methods of the programme (including
the use of personal information and results) were publicly
announced. The details were explained during a prepara-
tory meeting in late 2010.
Eligibility
Participation is open to all colposcopists involved in sec-
ondary prevention of cervical cancer at any level. Eligibility
extends to professionals from outside the regional area as
well as those working in the clinical setting and the private
sector. Access to the application is free of charge for all
users.
The idea that all professionals who are interested
should be given the opportunity to participate reflects
the increasing view that opportunistic screening should
be integrated into organised screening [36]. In all geo-
graphical areas targeted by organised screening systems,
a substantial volume of opportunistic screening co-
exists. It is generally agreed upon that organised screen-
ing could be improved by extending evaluation proce-
dures to include opportunistic activity [36]. Central to
this task are the creation of population-based databases
and the obligatory registration of all screening Pap
smears. By analogy, a web-based platform for colposcopy
QA can be used as a tool to extend the concept of inte-
gration of opportunistic screening from the basic level to
colposcopy assessment.
Design
The programme has a two-phase design.
(a) First QA session
In this baseline phase, which was carried out in early 2011,
the programme was targeted at the staff of colposcopists
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Participation was on a voluntary basis but was strongly
advised.
The web application was implemented and made ac-
cessible at the website of the regional Administration of
Emilia-Romagna. After obligatory registration, the colpo-
scopists logged-in with a user name and a password to
the web application, and underwent a test of their diag-
nostic performance.
They viewed a posted set of 50 colpophotographs
selected by the Committee and they classified each
according to the following variables: (1) colposcopic
impression; (2) visibility of the SCJ; (3) need for biopsy;
and (4) most appropriate biopsy site. The participants
were mutually unaware of their reports. They compiled
this information using an on-line reporting form and
immediately received a set of individual feedback data.
Table 1 shows the classification scheme. The variable
‘colposcopic impression’ was classified into four cat-
egories: negative; abnormal, grade 1; abnormal, grade 2;
and suspected invasive cancer. Despite the simplified
terminology, these categories were equivalent to those
of the International Federation for Cervical Pathology and
Colposcopy (IFCPC) classification of 2002, namely: nor-
mal colposcopic findings; abnormal colposcopic findings,
minor changes; abnormal colposcopic findings, major
changes; and colposcopic features suggestive of invasive
cancer [37]. Four colpophotographs representing these
categories are shown in the Additional file 2.
The first QA session ended with a colposcopy seminar.
The protocol details presented hereafter concern the fist








Not or not entirely visible




* The four categories of the variable ‘colposcopic impression’ were equivalent
to those of the International Federation for Cervical Pathology and Colposcopy
(IFCPC) classification of 2002, namely: normal colposcopic findings; abnormal
colposcopic findings, minor changes; abnormal colposcopic findings, major
changes; and colposcopic features suggestive of invasive cancer [37].
† Correctness of biopsy site according to the programme Steering
Committee's judgment.(b) Prospective activities
After this start-up phase, the programme will continue
along three main lines. Their planning is to be consid-
ered a work in progress, which will be updated as imple-
mentation progresses and results are achieved.Repeated QA sessions for screening colposcopists All
regional QA sessions that will be held in the future will
have the same general format as the first session. The
criteria for selection of cases, however, are open to mod-
ifications. For example, if a good level of diagnostic ac-
curacy for the most common colposcopic presentations
will be reached, images showing uncommon or rare
colposcopic patterns could be included in the test set.Enrollment of colposcopists from other settings and
other Italian regions This will offer the opportunity for
a comparative approach to analysis of our data. To this
end, however, a properly designed study needs to be
undertaken, possibly under the auspices of a national
screening authority. In particular, appropriate methods
will have to be developed in order to ensure the partici-
pation of an unselected sample of Italian screening
colposcopists.Permanent availability of a platform for exchange
and discussion of digital colposcopic images The
colpophotographs loaded by users will be evaluated by
the Committee with an empirical approach, along with
their potential uses. This material would enlarge the
spectrum of colposcopy patterns typical of routine prac-
tice, although its suitability for use in QA sessions would
need to be assessed.Concluding colposcopy seminar
The concluding event – and a major component – of
the first QA session was a colposcopy seminar. This will
also be the case for all future QA sessions designed for
the personnel staffing the screening centres. A colposcopy
seminar is an intensive course held by the Committee
which includes (1) the personal communication of individ-
ual test results to participants; (2) a statistical presentation
of overall test results; and (3) an interactive review of
slides of all digital colpophotographs. A seminar normally
lasts 5 hours.(a) Personal communication of individual test results
Each participant receives a personal report showing his data
for agreement with the Committee on the colposcopic im-
pression, visibility of the SCJ, need for biopsy, and selection
of biopsy site.
Bucchi et al. BMC Health Services Research 2013, 13:237 Page 7 of 11
http://www.biomedcentral.com/1472-6963/13/237(b) Presentation of overall test results
The plenary session begins with the presentation of overall
(group) results including total values, distributions, and
ranges of agreement percentages and kappa agreement co-
efficients for colposcopic impression, visibility of the SCJ,
need for biopsy, and selection of biopsy site.
(c) Interactive review of slides
The rationale of joint review of slides is that a profes-
sional interaction between the Committee and the par-
ticipants may expand the educational effect of individual
participation to the test. Slides are projected on a screen
in a darkened hall. Each slide is accompanied by infor-
mation regarding the colposcopic impression formulated
by the Committee and by the majority of participants,
the proportion of participants who agreed with the
Committee on the need for biopsy and on the most ap-
propriate site, and the most severe histological diagnosis.
Participants of the QA session are encouraged to discuss
the discrepancies between their evaluation and that by the
Committee. An independent external expert takes part in
the discussion, contributing complementary knowledge
and experience. The interactive review is meant to be a
discussion between peers. The Committee's classification
is primarily provided with the objective to make the dis-
cussion more focused and straightforward. The ultimate
purpose is to offer a forum for an open exchange of views
that may lead to more knowledge and more diagnostic
homogeneity.
Web application
The web application in which the preregistered participants
register, log-in, and access the test set of images through
the internet (https://sanita.regione.emilia-romagna.it/
colposcopia) is the technical core of the programme.
Details of the programming languages and the software
programme used to create the application, its structure
and design, and a description of pre-registration, registra-
tion, and log-in functions can be found in the Additional
file 3.
Selection of the test set of colpophotographs
(a) Acquisition of images
Two of us (PS and PG) selected a basic set of 250 high-
definition digital colpophotographs from the screening
centres of the two health care districts. Technical details
of acquisition of images are described in the Additional
file 4.
(b) Criteria
From the initial set of images, four of us (PC, PS, PG, and
SC) selected 50 images with the following characteristics:
(1) they were well-representative of the four categories of
the IFCPC classification of 2002 [37] (Table 1); (2) theywere of high technical quality; (3) the cervix was entirely
visible; (4) there was no visible excess mucus accumula-
tion; (5) there were no light reflections or colour artifacts
or shaded areas; (6) the patient had not been treated previ-
ously; and (7) information on patient age, last screening
Pap smear report, and HPV test result was available. Ori-
ginal histological information, including normal histology
and biopsy not performed, was known to the selectors but
was not assumed to represent a gold standard for the
colposcopic impression.
The rationale for criteria 1–5 was two-fold: first, a col-
poscopy QA programme should target the basic presen-
tations of normal and affected tissues of the cervix with
which to compare the spectrum of colposcopic patterns
encountered in practice; and, second, colposcopic images
used in a QA setting should be as least controversial as
possible. Controversies weaken the organisers’ credibility,
and decrease the educational effect of the programme.(c) Validity
Using high-quality images of classic colposcopic patterns
leads to an overestimate of agreement and accuracy
measures. In general, it is a requirement for external QA
schemes to simulate the daily practice conditions as
closely as possible. As far the current programme is
concerned, however, this is a purely theoretical argu-
ment, since we do not aim at interregional comparisons
with results obtained elsewhere using different test sets,
and the data on the colposcopists’ performance are not
used for administrative purposes.
Furthermore, examination of a test set of colposcopic
images is always and inevitably impossible to compare
with normal practice, because the test environment is
totally artificial and the test set includes a disproportion-
ately high proportion of abnormal colposcopic findings.
As a consequence, inclusion of imperfect images could
not significantly improve the comparability of the
programme with the daily practice conditions.
These limitations suggest that agreement measures on
colposcopic variables have no absolute significance, and
should only be used for internal comparisons for a given
test environment (for example: comparisons between
groups of colposcopists defined by the number of years
of experience, etc.).
Colposcopic variables
The colposcopic variables according to which to classify
the test set of 50 colpophotographs were selected based
on the following rationale.
(a) Colposcopic impression
The primary responsibility of the colposcopist is to rule
out the presence of invasive cancer. This involves the
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the presence and grade of a lesion, an appropriate recog-
nition of the entire transformation zone should be car-
ried out. The aim of colposcopy is to provide an
objective guide to differentiate between normal, minim-
ally abnormal and significantly abnormal colposcopic
findings, in order to select the site for biopsy. After
acetic acid application, the margins, colour tones, vascular
pattern, and surface contour are graded into minor
changes (or abnormal, grade 1) suggesting low-grade CIN
and major changes (or abnormal, grade 2) indicating high-
grade CIN.
(b) Visibility of the SCJ
The second key objective of colposcopic examination is
to assess the topographic distribution of the lesion, since
the endocervical dislocation of the abnormal transform-
ation zone occurs frequently. The colposcopist should be
able to determine the visibility of the SCJ in order to plan
further diagnostic and treatment procedures. Accurate
recognition of the SCJ has a major clinical impact, since
it yields useful information in tailoring the excisional
treatment.
(c, d) Need for biopsy and biopsy site
Identifying the areas of the cervix from which a biopsy
would be obtained is the key in order to rule out an
invasive disease. In fact, colposcopy is subject to high
biopsy sampling error rate [30]. The web application al-
lows the user to choose only one biopsy site. In a real
world situation, conversely, obtaining multiple biopsies
from large or multifocal lesions is a common approach.
In a clinical setting, moreover, the histological diagnosis
of biopsy specimens should be considered in context
with the colposcopic impression, the Pap smear report,
and the HPV test result. In case of substantial discrep-
ancy, a loop electrosurgical excision procedure may be
performed. This confirms that the overall sensitivity of
the diagnostic process cannot be directly inferred from
the sensitivity of colposcopically guided biopsy in a QA
environment.
Gold standards
The design of data analysis was based on precise as-
sumptions about the question of colposcopic and histo-
logical gold standards.
(a) Colposcopic gold standard
The fact that colposcopy is a subjective technique means
that an objective gold standard for colposcopic impression
is lacking, and that a considerable degree of observer vari-
ation is inevitable.
This provided the rationale for considering interobserver
agreement as a major outcome measure of the QAprogramme, since: (a) in the absence of a gold standard,
interobserver agreement is an acceptable measure of qual-
ity of colposcopic examination, especially in a large sample
of observers; and (b) reducing interobserver variation to a
low level is a priority objective for the screening service.
The Committee’s classification of images according to
colposcopic impression and visibility of the SCJ was not
considered to formally represent a gold standard, that is,
an absolute reference. However, the high level of expert-
ise of Committee members suggested to use their classi-
fication as a reference of sufficient quality for the public
health purposes of the programme. As a consequence,
the comparison between the participants and the Com-
mittee had a central role in data analysis, although it was
made using agreement statistics, not accuracy measures.
The biopsy sites selected by the colposcopists were
automatically classified into correct and incorrect, which
was inevitably treated as a gold standard. In the Commit-
tee’s classification, the impression of abnormal colposcopic
findings translated into an indication for biopsy, and the
impression of normal findings into the opposite indication.
In a small number of cases, the participating colposcopists
did not follow this criterion of equivalence. We assumed
that these responses could result from diagnostic uncer-
tainties rather than material errors, and we retained them
in analysis.(b) Histological gold standard
The Committee did not use the original histological
diagnosis as a gold standard to formulate a colposcopic
impression. The colposcopic impression is not a direct
predictor of the histological grading of a lesion, since
errors in the selection of biopsy site may result in the
missing of one quarter of prevalent CIN2 or CIN3 [2],
and there is only moderate agreement even between ex-
pert pathologists on the interpretation of biopsy and surgi-
cal specimens [38].
Despite this, many screening monitoring systems in-
clude a cross-tabulation of colposcopic impressions with
the most severe histological diagnoses. This is because
histological diagnosis can be considered a ‘public health
gold standard’. Accuracy of colposcopy towards histo-
logical diagnosis provides an approximate measure of
the probability for a woman to receive a false-negative
or false-positive colposcopy evaluation. For this reason,
a cross-tabulation of colposcopic impressions with the
most severe histological diagnoses was included among
the outcomes of data analysis.Analysis and evaluation issues
(a) Analysis of test results
Data analysis was mainly based on agreement statistics,
i.e., percent observed agreement and Cohen’s kappa
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gle colposcopist’s test results as well as the overall re-
sults, which were presented at the first colposcopy
seminar. Agreement statistics play a prominent role in the
development of diagnostic tests. Disagreements for par-
ticular diagnostic categories can be used to modify the
reporting system and improve the test performance.
A second stage of data analysis was planned for publica-
tion purposes. Results on colposcopic impression, decision
for biopsy, correctness of biopsy site, and other secondary
topics will be reported. Analysis of data on colposcopic
impression will include, among others, the evaluation of
statistical significance of differences between kappa
values, and the assessment of the degree and direction
of colposcopist-Committee disagreement. Analysis of
data on biopsy will include, among others, a logistic re-
gression analysis of factors associated with a correct de-
cision for biopsy and a correct selection of biopsy site.
(b) Evaluation of impact
To prospectively assess the effectiveness of the training
session in improving the diagnostic performance of the
staff, the correlation between the colposcopic impression
and the histological diagnosis will be evaluated using a
“before-after” approach, i.e., comparing data for the year
2012 with the years 2006–2011 on a regional basis.
Other approaches are impossible at present due to limi-
tations in data availability.
Ethics and funding considerations
The QA programme described in this protocol did not
involve patients or patient data and, according to the
Italian legislation, it did not require formal ethical com-
mittee approval. The digital colpophotographs used for
the programme were kept anonymous. Approval for
their use was obtained from the Direction Boards of the
screening centres of origin. Staff involved in data ana-
lysis had access only to deidentified physician data. The
application used for this programme conforms to the
technical and security specifications set by the Computer
Information Service of the regional Administration of
Emilia-Romagna.
The programme did not receive funding or assistance
from commercial organisations or external funding bodies.
Both direct and indirect costs were entirely paid by the
Department of Health of the Emilia-Romagna Region. The
funder had no role in the design of the protocol, the prep-
aration of the manuscript, or the decision to submit for
publication.Discussion
Several innovative digital colposcopy techniques have been
developed in the last years [1]. Despite the promisingresults of some studies, they have not yet been introduced
on a large scale at the office level. As a parallel problem,
web-based tools have been rarely used for colposcopy QA.
Although the combination of digital colposcopy imaging
with the communication infrastructure of the web would
greatly facilitate the implementation of mid/large scale
programmes, there have been very few examples of
intercolposcopist agreement study with large and defined
geographical basis [28].
The design of this programme was complicated by the
lack of a gold standard for colposcopy interpretation, the
subjectivity of criteria for selection of the test set of
colpophotographs, and the artificiality of the test condi-
tions. These well-known limitations suggest a cautious
interpretation of results, but do not constitute sufficient
justification for not implementing QA measures for col-
poscopy practice.
This programme fulfils some important theoretical re-
quirements for an effective QA [10]. With their back-
ground and long-standing experience in colposcopy, the
Committee members offer a specific professional leader-
ship to participants. The Committee operates on behalf
of and with approval from the regional Department of
Health and, thus, it works in a supportive environment.
Perhaps more important, the methods of the programme
and the use of personal information are well-accepted by
participants.
In other areas of medical practice, it has been sug-
gested that QA schemes are sustainable over time only
with the introduction of registration fees to cover run-
ning costs [20]. Our situation differs in that both direct
costs (start-up and maintenance) and indirect costs
(work hours lost) are paid by the regional Department of
Health. Moreover, since the programme involves the loss
of fewer work hours compared with residential
programmes, initial costs of implementation will be pro-
gressively recouped. In brief, continuity in the long term
will only depend on adequate turn-over of membership
of the Committee.
This programme is open to further developments. In
the area of basic training, we are considering the idea of
training sessions specifically tailored to the needs of
non-experienced colposcopists who are candidates to re-
place those going to retire. From many points of view,
however, the most interesting perspective is to undertake
a large interobserver agreement study among Italian
colposcopists in which the focus is on the IFCPC classi-
fication of 2011 [39].
The first QA session took place between December
2010 and February 2011. The first colposcopy seminar
was held in Bologna in May 2011. The interobserver
agreement data presented in that meeting, plus a selec-
tion of original analyses, will be reported in separate
publications.
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Additional file 1: Performance indicators routinely audited in
colposcopy clinics of the Emilia-Romagna Region of Italy and
observed data. A Table shows the list of performance indicators
routinely audited in the colposcopy clinics of the Emilia-Romagna Region
of Italy and, for each, the observed regional average and the range
between health care districts.
Additional file 2: Digital colpophotographs representing the four
categories of the International Federation for Cervical Pathology
and Colposcopy classification of 2002. Four figures show digital
colpophotographs taken with standard technique in one of the
screening centres of the Emilia-Romagna Region of Italy, and considered
by the programme Steering Committee to be well-representative of the
definitions of normal colposcopic findings, abnormal colposcopic
findings-minor changes, abnormal colposcopic findings-major changes,
and colposcopic features suggestive of invasive cancer (in the
programme, these categories were referred to as: negative; abnormal,
grade 1; abnormal, grade 2; and suspected invasive cancer).
Additional file 3: Technical details of the web application. A text
describes the programming languages and the software programme
used to create the application, its structure and design, and the pre-
registration, registration and log-in functions.
Additional file 4: Technical details of acquisition of colposcopic
images. A text describes the types and technical specifications of the
colposcopes, the video cameras, and the video editing softwares that
were used for acquisition of images.
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